Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide for Bronchorrhea in Mechanically Ventilated Patients
NCT02916433Phase 2Completed
- Sponsor
- Danbury Hospital
- Start
- Sep 2016
- Primary completion
- Feb 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of octreotide in bronchorrhea (2 arms), sponsored by Danbury Hospital. Primary endpoint: Bronchial Secretion Volume Over Preceding 24 Hour Period at 72 hours. Started Sep 2016; status: completed.
02
Drugs
octreotide
03
Conditions
bronchorrhea
Beyond the preview
Go deeper on NCT02916433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02916433.